NCT02815917View on ClinicalTrials.gov

Evaluation of D3 Receptor Occupancy Using FLUORTRIOPRIDE ([18F]FTP) PET/CT

PHASE1/PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
D3 Dopamine ReceptorCocaine-dependentHealthy Volunteer
Interventions
DRUG

[18F]FTP PET/CT

All PET/CT imaging sessions will include an injection of \[18F\]FTP. Pilot data will be collected to evaluate preliminary information on brain uptake of \[18F\]FTP in healthy volunteers and cocaine-dependent volunteers.

Trial Locations (1)

19104

University of Pennsylvania, Philadelphia

All Listed Sponsors
lead

University of Pennsylvania

OTHER

NCT02815917 - Evaluation of D3 Receptor Occupancy Using FLUORTRIOPRIDE ([18F]FTP) PET/CT | Biotech Hunter | Biotech Hunter